Migraine Treatment Medication Market, Global Outlook and Forecast 2023-2029

Report ID: MMG300560 | Category: Medical Care | Pages: 101 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global Migraine Treatment Medication market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Triptans Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Migraine Treatment Medication include GSK, Pfizer, Novartis, Teva, Sun Pharma, Grünenthal, Endo Pharmaceuticals, Merck and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Migraine is a neurological condition that typically causes painful headache attacks that occur with additional symptoms, such as sensitivity to light, sound, smell, or touch. Migraine treatment medications aim to alleviate or prevent migraine headaches.
This report aims to provide a comprehensive presentation of the global market for Migraine Treatment Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Treatment Medication. This report contains market size and forecasts of Migraine Treatment Medication in global, including the following market information:
Global Migraine Treatment Medication Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Migraine Treatment Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine Treatment Medication Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Migraine Treatment Medication Market Segment Percentages, by Type, 2022 (%)
    Triptans
    NSAIDs
    Others
Global Migraine Treatment Medication Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Migraine Treatment Medication Market Segment Percentages, by Application, 2022 (%)
    Acute Migraine
    Chronic Migraine
Global Migraine Treatment Medication Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Migraine Treatment Medication Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Migraine Treatment Medication revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Migraine Treatment Medication revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    GSK
    Pfizer
    Novartis
    Teva
    Sun Pharma
    Grünenthal
    Endo Pharmaceuticals
    Merck
    Johnson & Johnson
    AbbVie
    Abbott
    Bayer
    Eli Lilly
    Kowa Pharmaceuticals America
    AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Migraine Treatment Medication, market overview.
Chapter 2: Global Migraine Treatment Medication market size in revenue.
Chapter 3: Detailed analysis of Migraine Treatment Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Migraine Treatment Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Migraine Treatment Medication Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Migraine Treatment Medication Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Migraine Treatment Medication Overall Market Size
    2.1 Global Migraine Treatment Medication Market Size: 2022 VS 2029
    2.2 Global Migraine Treatment Medication Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Migraine Treatment Medication Players in Global Market
    3.2 Top Global Migraine Treatment Medication Companies Ranked by Revenue
    3.3 Global Migraine Treatment Medication Revenue by Companies
    3.4 Top 3 and Top 5 Migraine Treatment Medication Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Migraine Treatment Medication Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Migraine Treatment Medication Players in Global Market
        3.6.1 List of Global Tier 1 Migraine Treatment Medication Companies
        3.6.2 List of Global Tier 2 and Tier 3 Migraine Treatment Medication Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Migraine Treatment Medication Market Size Markets, 2022 & 2029
        4.1.2 Triptans
        4.1.3 NSAIDs
        4.1.4 Others
    4.2 By Type - Global Migraine Treatment Medication Revenue & Forecasts
        4.2.1 By Type - Global Migraine Treatment Medication Revenue, 2018-2023
        4.2.2 By Type - Global Migraine Treatment Medication Revenue, 2024-2029
        4.2.3 By Type - Global Migraine Treatment Medication Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Migraine Treatment Medication Market Size, 2022 & 2029
        5.1.2 Acute Migraine
        5.1.3 Chronic Migraine
    5.2 By Application - Global Migraine Treatment Medication Revenue & Forecasts
        5.2.1 By Application - Global Migraine Treatment Medication Revenue, 2018-2023
        5.2.2 By Application - Global Migraine Treatment Medication Revenue, 2024-2029
        5.2.3 By Application - Global Migraine Treatment Medication Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Migraine Treatment Medication Market Size, 2022 & 2029
    6.2 By Region - Global Migraine Treatment Medication Revenue & Forecasts
        6.2.1 By Region - Global Migraine Treatment Medication Revenue, 2018-2023
        6.2.2 By Region - Global Migraine Treatment Medication Revenue, 2024-2029
        6.2.3 By Region - Global Migraine Treatment Medication Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Migraine Treatment Medication Revenue, 2018-2029
        6.3.2 US Migraine Treatment Medication Market Size, 2018-2029
        6.3.3 Canada Migraine Treatment Medication Market Size, 2018-2029
        6.3.4 Mexico Migraine Treatment Medication Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Migraine Treatment Medication Revenue, 2018-2029
        6.4.2 Germany Migraine Treatment Medication Market Size, 2018-2029
        6.4.3 France Migraine Treatment Medication Market Size, 2018-2029
        6.4.4 U.K. Migraine Treatment Medication Market Size, 2018-2029
        6.4.5 Italy Migraine Treatment Medication Market Size, 2018-2029
        6.4.6 Russia Migraine Treatment Medication Market Size, 2018-2029
        6.4.7 Nordic Countries Migraine Treatment Medication Market Size, 2018-2029
        6.4.8 Benelux Migraine Treatment Medication Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Migraine Treatment Medication Revenue, 2018-2029
        6.5.2 China Migraine Treatment Medication Market Size, 2018-2029
        6.5.3 Japan Migraine Treatment Medication Market Size, 2018-2029
        6.5.4 South Korea Migraine Treatment Medication Market Size, 2018-2029
        6.5.5 Southeast Asia Migraine Treatment Medication Market Size, 2018-2029
        6.5.6 India Migraine Treatment Medication Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Migraine Treatment Medication Revenue, 2018-2029
        6.6.2 Brazil Migraine Treatment Medication Market Size, 2018-2029
        6.6.3 Argentina Migraine Treatment Medication Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Migraine Treatment Medication Revenue, 2018-2029
        6.7.2 Turkey Migraine Treatment Medication Market Size, 2018-2029
        6.7.3 Israel Migraine Treatment Medication Market Size, 2018-2029
        6.7.4 Saudi Arabia Migraine Treatment Medication Market Size, 2018-2029
        6.7.5 UAE Migraine Treatment Medication Market Size, 2018-2029
7 Migraine Treatment Medication Companies Profiles
    7.1 GSK
        7.1.1 GSK Company Summary
        7.1.2 GSK Business Overview
        7.1.3 GSK Migraine Treatment Medication Major Product Offerings
        7.1.4 GSK Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.1.5 GSK Key News & Latest Developments
    7.2 Pfizer
        7.2.1 Pfizer Company Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Migraine Treatment Medication Major Product Offerings
        7.2.4 Pfizer Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.2.5 Pfizer Key News & Latest Developments
    7.3 Novartis
        7.3.1 Novartis Company Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Migraine Treatment Medication Major Product Offerings
        7.3.4 Novartis Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.3.5 Novartis Key News & Latest Developments
    7.4 Teva
        7.4.1 Teva Company Summary
        7.4.2 Teva Business Overview
        7.4.3 Teva Migraine Treatment Medication Major Product Offerings
        7.4.4 Teva Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.4.5 Teva Key News & Latest Developments
    7.5 Sun Pharma
        7.5.1 Sun Pharma Company Summary
        7.5.2 Sun Pharma Business Overview
        7.5.3 Sun Pharma Migraine Treatment Medication Major Product Offerings
        7.5.4 Sun Pharma Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.5.5 Sun Pharma Key News & Latest Developments
    7.6 Grünenthal
        7.6.1 Grünenthal Company Summary
        7.6.2 Grünenthal Business Overview
        7.6.3 Grünenthal Migraine Treatment Medication Major Product Offerings
        7.6.4 Grünenthal Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.6.5 Grünenthal Key News & Latest Developments
    7.7 Endo Pharmaceuticals
        7.7.1 Endo Pharmaceuticals Company Summary
        7.7.2 Endo Pharmaceuticals Business Overview
        7.7.3 Endo Pharmaceuticals Migraine Treatment Medication Major Product Offerings
        7.7.4 Endo Pharmaceuticals Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.7.5 Endo Pharmaceuticals Key News & Latest Developments
    7.8 Merck
        7.8.1 Merck Company Summary
        7.8.2 Merck Business Overview
        7.8.3 Merck Migraine Treatment Medication Major Product Offerings
        7.8.4 Merck Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.8.5 Merck Key News & Latest Developments
    7.9 Johnson & Johnson
        7.9.1 Johnson & Johnson Company Summary
        7.9.2 Johnson & Johnson Business Overview
        7.9.3 Johnson & Johnson Migraine Treatment Medication Major Product Offerings
        7.9.4 Johnson & Johnson Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.9.5 Johnson & Johnson Key News & Latest Developments
    7.10 AbbVie
        7.10.1 AbbVie Company Summary
        7.10.2 AbbVie Business Overview
        7.10.3 AbbVie Migraine Treatment Medication Major Product Offerings
        7.10.4 AbbVie Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.10.5 AbbVie Key News & Latest Developments
    7.11 Abbott
        7.11.1 Abbott Company Summary
        7.11.2 Abbott Business Overview
        7.11.3 Abbott Migraine Treatment Medication Major Product Offerings
        7.11.4 Abbott Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.11.5 Abbott Key News & Latest Developments
    7.12 Bayer
        7.12.1 Bayer Company Summary
        7.12.2 Bayer Business Overview
        7.12.3 Bayer Migraine Treatment Medication Major Product Offerings
        7.12.4 Bayer Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.12.5 Bayer Key News & Latest Developments
    7.13 Eli Lilly
        7.13.1 Eli Lilly Company Summary
        7.13.2 Eli Lilly Business Overview
        7.13.3 Eli Lilly Migraine Treatment Medication Major Product Offerings
        7.13.4 Eli Lilly Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.13.5 Eli Lilly Key News & Latest Developments
    7.14 Kowa Pharmaceuticals America
        7.14.1 Kowa Pharmaceuticals America Company Summary
        7.14.2 Kowa Pharmaceuticals America Business Overview
        7.14.3 Kowa Pharmaceuticals America Migraine Treatment Medication Major Product Offerings
        7.14.4 Kowa Pharmaceuticals America Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.14.5 Kowa Pharmaceuticals America Key News & Latest Developments
    7.15 AstraZeneca
        7.15.1 AstraZeneca Company Summary
        7.15.2 AstraZeneca Business Overview
        7.15.3 AstraZeneca Migraine Treatment Medication Major Product Offerings
        7.15.4 AstraZeneca Migraine Treatment Medication Revenue in Global Market (2018-2023)
        7.15.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Migraine Treatment Medication Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?